Effects of sibutramine and orlistat on mood in obese and overweight subjects: A randomised study
- 1 March 2008
- journal article
- research article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 18 (3) , 207-210
- https://doi.org/10.1016/j.numecd.2006.10.003
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A review of the metabolic effects of sibutramineCurrent Medical Research and Opinion, 2005
- Sibutramine treatment in obesity: initial eating behaviour in relation to weight loss results and changes in moodPharmacological Research, 2005
- Depressive Mood and Abdominal Fat Distribution in Overweight Premenopausal WomenObesity Research, 2005
- The effects of orlistat on metabolic parameters and other cardiovascular risk factorsDiabetes & Metabolism, 2005
- Are Mood Disorders and Obesity Related? A Review for the Mental Health ProfessionalThe Journal of Clinical Psychiatry, 2004
- XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) StudyDiabetes Care, 2004
- A Randomized, Double-blind, Placebo-Controlled Study of Sibutramine in the Treatment of Binge-Eating DisorderArchives of General Psychiatry, 2003
- An Open-Label Trial of Sibutramine in Obese Patients With Binge-Eating DisorderThe Journal of Clinical Psychiatry, 2002
- Effect of sibutramine on weight maintenance after weight loss: a randomised trialThe Lancet, 2000
- Predictors and Effects of Long-term Dieting on Mental Well-being and Weight Loss in Obese WomenAppetite, 1994